Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brew Atkinson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Human Reproduction (Oxford, England)|June 26, 2007
Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitusCon Mallidis, Ishola Agbaje, Deirdre Rogers, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Low- and standard-dose corticotropin and insulin hypoglycemia testing in the assessment of hypothalamic-pituitary-adrenal function after pituitary surgeryC Hamish Courtney, Andrew S McAllister, Patrick M Bell, et al.
Journal of Diabetes and Its Complications|February 25, 2014
The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trialR Neil A Black, Cieran N Ennis, Ian S Young, et al.
Diabetes Care|March 1, 2005
Reduced prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20-year periodJohn R Lindsay, Laurence Kennedy, A Brew Atkinson, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2013
Effects on insulin action of adding low-dose thiazide to angiotensin-converting enzyme inhibitor in essential hypertensionClaire M McHenry, A Brew Atkinson, Steven J Hunter, et al.
Clinical Endocrinology|March 17, 2012
Effects of dehydroepiandrosterone sulphate (DHEAS) replacement on insulin action and quality of life in hypopituitary females: a double-blind, placebo-controlled studyClaire M McHenry, Patrick M Bell, Steven J Hunter, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutationFred Williams, Steven Hunter, Lisa Bradley, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysisRasa Kazlauskaite, Arthur T Evans, Carmen V Villabona, et al.
The New England Journal of Medicine|January 7, 2011
AIP mutation in pituitary adenomas in the 18th century and todayHarvinder S Chahal, Karen Stals, Martina Unterländer, et al.
Human Mutation|October 6, 2009
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHDChristopher J Ricketts, Julia R Forman, Eleanor Rattenberry, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Human Reproduction (Oxford, England)|June 26, 2007
Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitusCon Mallidis, Ishola Agbaje, Deirdre Rogers, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Low- and standard-dose corticotropin and insulin hypoglycemia testing in the assessment of hypothalamic-pituitary-adrenal function after pituitary surgeryC Hamish Courtney, Andrew S McAllister, Patrick M Bell, et al.
Journal of Diabetes and Its Complications|February 25, 2014
The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trialR Neil A Black, Cieran N Ennis, Ian S Young, et al.
Diabetes Care|March 1, 2005
Reduced prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20-year periodJohn R Lindsay, Laurence Kennedy, A Brew Atkinson, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2013
Effects on insulin action of adding low-dose thiazide to angiotensin-converting enzyme inhibitor in essential hypertensionClaire M McHenry, A Brew Atkinson, Steven J Hunter, et al.
Clinical Endocrinology|March 17, 2012
Effects of dehydroepiandrosterone sulphate (DHEAS) replacement on insulin action and quality of life in hypopituitary females: a double-blind, placebo-controlled studyClaire M McHenry, Patrick M Bell, Steven J Hunter, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutationFred Williams, Steven Hunter, Lisa Bradley, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysisRasa Kazlauskaite, Arthur T Evans, Carmen V Villabona, et al.
The New England Journal of Medicine|January 7, 2011
AIP mutation in pituitary adenomas in the 18th century and todayHarvinder S Chahal, Karen Stals, Martina Unterländer, et al.
Human Mutation|October 6, 2009
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHDChristopher J Ricketts, Julia R Forman, Eleanor Rattenberry, et al.
Pageof 3